APR 21, 2020 8:05 AM PDT

Scientists develop tumor immunity map

A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecules. The map provides hope for expanding the number of patients who could be receptive to immunotherapy treatments. In developing the map, the research team behind the study analyzed human leukocyte antigens (HLAs) that are not typically included in HLA-based immunotherapies.

HLAs are important because HLA-restricted T cell responses can induce antitumor effects in cancer patients; however, previous studies have typically focused on the few HLA alleles prevalent in a specific subset of ethnic groups. These researchers wanted to expand the knowledge to include a wider population.

"Most studies have focused on HLA proteins that are commonly found in the general population," explains co-first author Kenji Murata, a postdoctoral fellow at the Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. "We have developed a new technique that allows the sampling of underrepresented HLA proteins to find peptides or antigens that can induce an anti-tumor immune response. We can then stimulate the patient's own immune cells with those peptides and give them back to the patient to help treat their cancer."

In their analysis, the team isolated T cells from patients with melanoma with 25 different types of HLAs. This combination let them analyze T cell interactions with more than 800 different antigen peptides. As the authors write in their study, “We were able to determine the specificity, on average, of 12.2% of the tumor-infiltrating T lymphocytes recognizing a mean of 3.1 shared antigen-derived epitopes across HLA-A, B, and C. Furthermore, we isolated a number of cognate T cell receptor genes with tumor reactivity.”

The researchers hope their map will broaden the audience of those cancer patients who are receptive to immunotherapies. "By querying human melanoma-derived T cells and using novel HLA proteins bearing common tumor antigens, we have been able to discover both new and existing immunologically active antigens in tumors," concludes senior author Naoto Hirano, Senior Scientist at the Princess Margaret Cancer Centre. "Our strategy allows for a more complete examination of the immune response and development of novel cancer vaccines and immunotherapies for a broader group of patients not limited by HLA prevalence or tumor mutation burden."

Sources: eLife, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
DEC 02, 2020
Cancer
Investigating the Active Components of an Herbal Mushroom
DEC 02, 2020
Investigating the Active Components of an Herbal Mushroom
When people think of traditional medicine, often what comes to mind are the old herbal medical practices in Asian countr ...
DEC 14, 2020
Cancer
Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer
DEC 14, 2020
Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer
Diagnostics is one of the key pillars of modern medicine. Diagnostics allows patients and doctors to identify a problem ...
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
JAN 11, 2021
Cancer
The habit-forming dangers of tobacco in young people
JAN 11, 2021
The habit-forming dangers of tobacco in young people
New research published today in the online edition of Pediatrics reports on the habit-forming dangers of tobacco pr ...
JAN 14, 2021
Microbiology
Decontaminating the Cancer Microbiome
JAN 14, 2021
Decontaminating the Cancer Microbiome
Valid scientific conclusions require a solid foundation of good data that comes from reliable techniques. Studies that i ...
Loading Comments...